Among the nearly 12 million US cancer survivors, there are 1.1 million who have been diagnosed with colon or rectal cancer.
The number of all US cancer survivors has increased steadily from about 3.8 million in 1971 to 9.8 million in 2001 to 11.7 million in 2007.
More than half of survivors had colorectal, breast, or prostate cancer.
Individuals are considered cancer survivors from the time of diagnosis through the balance of their lives. Read the rest of this entry »
Some of the most surprising data presented at the GI Symposium in January 2011 in San Francisco was the negative result of the European trial called AVANT.
Dr. HJ Lenz
In that clinical trial patients who underwent a curative resection for colon cancer received either FOLFOX or FOLFOX with Avastin® (bevacizumab) treatment after their surgery. Chemotherapy was given over 6 months, but patients who were randomly selected for Avastin received 6 months with chemotherapy and additional 6 months alone after chemotherapy ended for a total of 12 months of Avastin. Read the rest of this entry »
March 23rd was GI Nurses and Associates Day.
So today, better late than never, we’re sending a big bunch of thank-yous to those gastrointestinal nurses and associates who are doing so much to end colorectal cancer.
It’s their skill, dedication, and good care that makes a scary colonoscopy safe and easier for us.
If you see a GI nurse today, give them a hug — or a pat on the hand as you doze off.
One year ago today, the President signed into law the biggest transformation of our health care system in decades. Whether you favored or opposed the enactment of the Patient Protection and Affordable Care Act (PL 111-148, PL 111-152) (the Affordable Care Act), a full understanding of the new law is essential.
The Affordable Care Act changes many areas of health care, and will significantly impact cancer care. Fight Colorectal Cancer has all the information you need to understand the impact of health reform on colorectal cancer patients.
On our “Health Reform and You” webpage, you’ll find information explaining the law and its impact on colorectal cancer patients, such as:
Fight Colorectal Cancer is giving you the opportunity to talk to researchers and medical professionals in April and May through online webinars designed to bring the science of treating colorectal cancer down to the personal.
The latest news from the petri dish
Wednesday, April 20, 2011
8 – 9 PM Eastern
Dr. Yaeger at work in her lab
Dr. Rona Yaeger will discuss the research she has been conducting over the past year with the grant she received as part of Fight Colorectal Cancer’s Lisa Fund research program.
Dr. Yaeger’s research focused on inhibiting the AKT pathway in colorectal cancer cells. She conducted basic research to determine how inhibitors to the pathway might affect cells of patients who have mutated KRAS and are resistant to EGFR inhibiting drugs. Dr. Yaeger has also been conducting a phase II clinical trial with an AKT inhibitor for patients with metastatic colorectal cancer who have normal (wild type) KRAS.
If you are interested in learning more about the future of cancer treatments, or if you’ve ever donated to the Fight Colorectal Cancer Lisa Fund, do not miss this webinar!
Together we are Strong
